Cargando…

Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation

BACKGROUND: Pharmacogenetic (PGx) testing for germline variants in the DPYD and UGT1A1 genes can be used to guide fluoropyrimidine and irinotecan dosing, respectively. Despite the known association between PGx variants and chemotherapy toxicity, preemptive testing prior to chemotherapy initiation is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau-Min, Kelsey S., Varughese, Lisa A., Nelson, Maria N., Cambareri, Christine, Reddy, Nandi J., Oyer, Randall A., Teitelbaum, Ursina R., Tuteja, Sony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742388/ https://www.ncbi.nlm.nih.gov/pubmed/34996412 http://dx.doi.org/10.1186/s12885-022-09171-6

Ejemplares similares

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
por: Varughese, Lisa A., et al.
Publicado: (2021)

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing
por: Varughese, Lisa A., et al.
Publicado: (2022)

Multi-site investigation of strategies for the clinical implementation of preemptive pharmacogenetic testing
por: Duarte, Julio D., et al.
Publicado: (2021)

PREEMPTIVE PHARMACOGENETIC TESTING: EXPLORING THE KNOWLEDGE AND PERSPECTIVES OF UNITED STATES PAYERS
por: Keeling, Nicholas J., et al.
Publicado: (2017)

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population
por: Verma, Shefali S., et al.
Publicado: (2022)

Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patients
por: Del Re, Marzia, et al.
Publicado: (2015)

Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
por: Bank, P. C. D., et al.
Publicado: (2019)

Lessons from clinical implementation of a preemptive pharmacogenetic panel as part of a testing pilot program with an employer-sponsored medical plan
por: Norris, Madeline, et al.
Publicado: (2023)

From non-preemptive to preemptive scheduling using synchronization synthesis
por: Černý, Pavol, et al.
Publicado: (2016)

Perioperative Comparison of Preemptive and Non-Preemptive Renal Transplant Recipients
por: Aytekin, Sami, et al.
Publicado: (2020)

Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China
por: Yuan, Wei, et al.
Publicado: (2016)

Identifying Barriers to Preemptive Kidney Transplantation in a Living Donor Transplant Cohort
por: Helmick, Ryan A., et al.
Publicado: (2018)

Pharmacogenetics–Based Preliminary Algorithm to Predict the Incidence of Infection in Patients Receiving Cytotoxic Chemotherapy for Hematological Malignancies: A Discovery Cohort
por: Martinez, Matias F., et al.
Publicado: (2021)

Preemptive SARS patents
por: Brickley, Peg
Publicado: (2003)

Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users
por: Chanfreau-Coffinier, Catherine, et al.
Publicado: (2019)

Glutathione S-transferases genes variants and chemotherapy efficacy in gastrointestinal cancer patients: a meta-analysis based on 50 pharmacogenetic studies
por: Sun, Yuesheng, et al.
Publicado: (2019)

Comparison of the Efficacy of Pregabalin and Gabapentin for Preemptive Analgesia in Laparoscopic Cholecystectomy Patients: A Randomised Double-Blind Study
por: Kaur, Simrit, et al.
Publicado: (2023)

Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland
por: Begré, Ursina B. M., et al.
Publicado: (2022)

Preemptive Medicine for Cerebral Aneurysms
por: AOKI, Tomohiro, et al.
Publicado: (2016)

Non-Preemptive Tree Packing
por: Lendl, Stefan, et al.
Publicado: (2022)

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting
por: Cavallari, LH, et al.
Publicado: (2017)

Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative
por: Lau-Min, Kelsey S., et al.
Publicado: (2020)

Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2015)

The effect of race coefficients on preemptive listing for kidney transplantation
por: Abate, Mersema, et al.
Publicado: (2021)

The Efficacy of Preemptive Analgesia With Pregabalin in Septoplasty
por: Kim, Joon Ho, et al.
Publicado: (2014)

Preemptive analgesia with Ketamine for Laparoscopic cholecystectomy
por: Singh, Harsimran, et al.
Publicado: (2013)

Preemptive Striking in Individual and Group Conflict
por: Mifune, Nobuhiro, et al.
Publicado: (2016)

Vascular functional tests and preemptive medicine
por: Tanaka, Atsushi, et al.
Publicado: (2020)

The Emotional Mechanisms of Interpersonal Preemptive Behavior
por: Liu, Lei, et al.
Publicado: (2022)

Preemptive Therapy in Cryptococcosis Adjusted for Outcomes
por: Messina, Fernando, et al.
Publicado: (2023)

Melatonin as preemptive analgesic for intraoperative pain
por: Katariya, Chanchal, et al.
Publicado: (2023)

Employment and ability to work after kidney transplantation in the Netherlands: The impact of preemptive versus non‐preemptive kidney transplantation
por: Visser, Annemieke, et al.
Publicado: (2022)

Pharmacogenetic variants and risk of remdesivir‐associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID‐19
por: Tuteja, Sony, et al.
Publicado: (2022)

Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma
por: Goričar, Katja, et al.
Publicado: (2017)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
por: Stadler, Michael, et al.
Publicado: (2022)

Disorders of gastrointestinal hypomotility
por: Bielefeldt, Klaus, et al.
Publicado: (2016)

What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
por: Jameson, Adam, et al.
Publicado: (2021)

Quantifying the impact of the COVID‐19 pandemic on gastrointestinal cancer care delivery
por: Perkons, Nicholas R., et al.
Publicado: (2021)

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2018)

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy
por: Virgili Manrique, Anna C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0t63ikhcq3p0mcqa3ujpskjb6n